// App-Quantinova.ai

2464 : Disrupting the epigenetic modifier HMGA2 in DIPG and GBM inhibits tumor invasion, growth and tumorigenicity

Researchers

Presenter

  • Harpreet Kaur

Principal Investigators

  • Marianne Hutt-Cabezas

  • Isabella Taylor

  • Melanie Weingart

  • Fausto Rodriguez

  • Charles G. Eberhart

  • Eric H. Raabe

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Diffuse intrinsic pontine glioma

  • High-Grade Gliomas

  • Brain cancer

  • Glioblastoma

  • Gliomas

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • High Mobility Group AT-Hook 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved